Showing results (81-90 of 829) with videos related to
Sort By:
Pageof 83
Scandinavian Journal of Clinical and Laboratory Investigation|January 25, 2012
The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABPStine E Nielsen, Kasper Rossing, Georg Hess, et al.Kidney International|June 12, 2014
Improved prognosis of diabetic nephropathy in type 1 diabetesGudbjörg Andrésdóttir, Majken L Jensen, Bendix Carstensen, et al.Journal of Negative Results in Biomedicine|May 10, 2011
The CTGF -945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetesAmélie Dendooven, Tri Q Nguyen, Lodewijk Brosens, et al.Seminars in Nephrology|March 16, 2004
Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end pointsHans-Henrik Parving, Steen Andersen, Peter Jacobsen, et al.Journal of Hypertension|November 7, 2007
Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up studyAnne Sofie Astrup, Flemming S Nielsen, Peter Rossing, et al.BMJ (Clinical Research Ed.)|April 21, 2004
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort studyPeter Hovind, Lise Tarnow, Peter Rossing, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2016
Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 studyMorten Lindhardt, Frederik Persson, Petra Zürbig, et al.Diabetes Care|October 30, 2008
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuriaCamilla Noelle Rathcke, Frederik Persson, Lise Tarnow, et al.Journal of Diabetes and Its Complications|July 15, 2022
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk enginesElisabeth B Stougaard, Peter Rossing, David Cherney, et al.Kidney International. Supplement|October 16, 2004
Beneficial impact on cardiovascular risk factors by dual blockade of the renin-angiotensin system in diabetic nephropathyPeter Jacobsen, Hans-Henrik ParvingPageof 83